Harmonic motion imaging guided focused ultrasound (HMIgFUS) for Breast Cancer Stage 1

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Breast Cancer Stage 1+1 MoreHarmonic motion imaging guided focused ultrasound (HMIgFUS) - Procedure
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trial is testing whether a new ultrasound guidance and monitoring system is effective for treating early stage breast cancer.

Eligible Conditions
  • Breast Cancer Stage 1
  • Fibroadenoma

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: From the date of ablation and imaging to the date of pathological results (approximately 1 week)

Week 1
Number of patients with ablation
R2 value of ablated lesion area
R2 value of ablated lesion depth
R2 value of ablated lesion width

Trial Safety

Trial Design

1 Treatment Group

HMIgFUS
1 of 1

Experimental Treatment

36 Total Participants · 1 Treatment Group

Primary Treatment: Harmonic motion imaging guided focused ultrasound (HMIgFUS) · No Placebo Group · N/A

HMIgFUS
Procedure
Experimental Group · 1 Intervention: Harmonic motion imaging guided focused ultrasound (HMIgFUS) · Intervention Types: Procedure

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: from the date of ablation and imaging to the date of pathological results (approximately 1 week)

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,297 Previous Clinical Trials
1,613,201 Total Patients Enrolled
Elisa Konofagou, PhDPrincipal InvestigatorProfessor of Biomedical Engineering
2 Previous Clinical Trials
56 Total Patients Enrolled

Eligibility Criteria

Age 18+ · Female Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are scheduled to receive surgical resection of the tumor by the clinical care team.